黑料网

Endocrine disruption; Environmental toxins; Biochemical mechanisms; Hormone synthesis; Hormone signaling pathways; Bisphenol A (BPA); Organophosphate pesticides

Introduction

Endocrine disruption caused by environmental toxins has emerged as a critical public health concern globally. These toxins, originating from industrial pollutants, pesticides, plasticizers, and other sources, can interfere with hormone synthesis, metabolism, and signaling pathways. The consequences include reproductive disorders, metabolic dysregulation, developmental abnormalities, and increased susceptibility to diseases such as cancer. This review aims to delve into the biochemical mechanisms underlying these disruptions, providing insights into how environmental toxins exert their deleterious effects on endocrine function [1,3].

Biochemical mechanisms of endocrine disruption

Environmental toxins exert their effects through various biochemical pathways within the endocrine system. One prominent mechanism involves the mimicry of natural hormones by synthetic chemicals. For instance, bisphenol A (BPA) mimics estrogen, binding to estrogen receptors and altering gene expression patterns that regulate reproductive and developmental processes [4,5]. Similarly, organophosphate pesticides can interfere with thyroid hormone metabolism by inhibiting enzymes involved in hormone synthesis and degradation. Another critical mechanism is the modulation of hormone synthesis and secretion. Polycyclic aromatic hydrocarbons (PAHs), found in air pollution and cigarette smoke, can disrupt steroidogenesis by altering the activity of enzymes such as aromatase and 17β-hydroxysteroid dehydrogenase [6]. This disruption can lead to imbalances in sex hormone levels, contributing to reproductive disorders and cancers. Furthermore, environmental toxins can disrupt hormone signaling pathways by interfering with receptor activation or downstream signaling cascades. Phthalates, commonly used as plasticizers, can antagonize androgen receptors or interfere with insulin signaling pathways, contributing to metabolic disorders such as diabetes and obesity. The impact of environmental toxins on the hypothalamic-pituitary-adrenal (HPA) axis is also noteworthy. Persistent organic pollutants (POPs) like dioxins and PCBs can disrupt cortisol synthesis and release, affecting stress responses and immune function [7].

Clinical implications and public health relevance

The biochemical disruptions caused by environmental toxins have profound clinical implications. Epidemiological studies have linked exposure to these toxins with an increased incidence of endocrinerelated diseases, including infertility, hormone-dependent cancers, and neurodevelopmental disorders. Vulnerable populations such as pregnant women, infants, and the elderly are particularly at risk due to heightened sensitivity to endocrine disruption [8]. From a public health perspective, regulatory measures and environmental policies play a crucial role in minimizing exposure to these toxins. Efforts to identify and phase out hazardous chemicals, promote eco-friendly industrial practices, and enhance monitoring of environmental quality are essential steps towards mitigating the health impacts of endocrine disruption.

Future directions

Future research should focus on elucidating the long-term effects of chronic low-dose exposure to environmental toxins, as well as exploring synergistic effects of multiple chemicals. Advances in analytical techniques, such as metabolomics and systems biology, can provide deeper insights into the complex interactions between environmental toxins and endocrine pathways. Additionally, there is a need for biomonitoring studies to assess human exposure levels and biomarkers of endocrine disruption accurately.

Materials and Methods

Literature search strategy

Describe the systematic approach used to identify relevant studies and literature. Include databases searched, search terms (keywords provided earlier), and inclusion/exclusion criteria for selecting studies.

Selection of studies

Outline the process for selecting studies, including screening of titles and abstracts, full-text review, and reasons for inclusion/exclusion. Specify any criteria used to assess study quality and relevance.

Data extraction

Detail the data extraction process, including variables of interest extracted from each study (e.g., type of toxin, exposure levels, outcomes measured). Discuss methods used to ensure consistency and accuracy in data extraction.

Biochemical mechanisms analysis

Describe the approach used to analyze and synthesize biochemical mechanisms underlying endocrine disruption caused by environmental toxins. Discuss how data from selected studies were synthesized to identify common mechanisms and pathways.

Clinical implications assessment

Explain how clinical implications of endocrine disruption were assessed based on the synthesized evidence. Discuss methodologies used to analyze epidemiological data linking toxin exposure to endocrine-related diseases.

Public health relevance evaluation

Outline methods used to evaluate the public health relevance of findings, including considerations of vulnerable populations, regulatory policies, and implications for health promotion and disease prevention.

Future research directions discussion

Discuss the methods used to identify gaps in knowledge and propose future research directions. Include methodologies for evaluating longterm effects, synergistic effects of multiple toxins, and advancements in biomonitoring and analytical techniques.

Ethical considerations

Address any ethical considerations related to the review process, such as handling of sensitive data or conflicts of interest. Specify statistical methods used to analyze quantitative data, such as metaanalyses or descriptive statistics. Include details on software used and parameters for data synthesis.

Reporting standards

Ensure compliance with reporting standards for systematic reviews and meta-analyses (e.g., PRISMA guidelines) or other relevant guidelines specific to the field of endocrine disruption and environmental health.

Limitations

Acknowledge limitations of the review process, including potential biases in study selection, data extraction, and synthesis. Discuss how these limitations may impact the interpretation of results.

Validation of findings

Discuss methods used to validate findings, such as peer review, expert consultation, or comparison with existing systematic reviews and meta-analyses.

Data availability statement

Provide information on the availability of data supporting the review findings, including sources for accessing primary studies or datasets used in the analysis.

Results

Increased incidence of endocrine-related diseases: Evidence linking environmental toxin exposure to higher rates of reproductive disorders, hormone-dependent cancers (e.g., breast, prostate), and metabolic dysregulation (e.g., diabetes, obesity).

Biochemical mechanisms elucidation: Understanding how environmental toxins interfere with hormone synthesis, metabolism, and signaling pathways, such as through hormone receptor mimicry or enzyme inhibition.

Public health implications: Highlighting the significance of regulatory measures to minimize exposure to harmful chemicals, potentially reducing the burden of endocrine-related diseases in vulnerable populations.

Need for biomonitoring and regulatory policies: Emphasizing the importance of biomonitoring studies to assess human exposure levels and the development of robust regulatory policies to protect public health.

Future research directions: Identifying gaps in knowledge, such as long-term effects of chronic low-dose exposure and synergistic effects of multiple toxins, to guide future research and policy development.

These results underscore the complex interplay between environmental toxins and endocrine disruption, emphasizing the importance of interdisciplinary research and proactive public health strategies.

Discussion

Environmental toxins exert profound effects on human health by disrupting endocrine function through various biochemical mechanisms [9]. This discussion synthesizes the findings regarding the mechanisms of action, clinical implications, public health relevance, and future research directions highlighted in this review.

Mechanisms of endocrine disruption

The biochemical mechanisms through which environmental toxins disrupt endocrine function are diverse and complex. Key mechanisms include:

Hormone mimicry: Synthetic chemicals such as bisphenol A (BPA) mimic natural hormones like estrogen, binding to hormone receptors and altering gene expression patterns. This mimicry can lead to dysregulated reproductive and developmental processes.

Enzyme inhibition: Certain toxins, including organophosphate pesticides and polycyclic aromatic hydrocarbons (PAHs), interfere with enzyme activities involved in hormone synthesis and metabolism. For example, PAHs can inhibit aromatase, affecting estrogen levels, while organophosphates can disrupt thyroid hormone metabolism.

Disruption of signaling pathways: Environmental toxins can interfere with hormone signaling pathways by either activating or blocking hormone receptors, thereby disrupting downstream signaling cascades crucial for normal physiological functions.

Effects on the HPA axis: Persistent organic pollutants (POPs) like dioxins and PCBs can alter cortisol synthesis and release, impacting stress responses and immune function.

Clinical implications and public health relevance

The disruptions caused by environmental toxins have significant clinical implications, contributing to the rise in endocrine-related diseases. Epidemiological studies consistently link exposure to toxins with increased risks of infertility, hormone-dependent cancers, metabolic disorders, and neurodevelopmental abnormalities. Vulnerable populations, such as pregnant women, infants, and the elderly, are particularly at risk due to their heightened susceptibility to endocrine disruption [10]. From a public health perspective, regulatory measures are crucial to mitigate exposure to hazardous chemicals. Policies aimed at reducing environmental pollution, promoting safer industrial practices, and enhancing biomonitoring efforts are essential steps toward protecting human health from the adverse effects of endocrine disruption.

Future directions

Future research should focus on several critical areas to advance our understanding and mitigate the impacts of environmental toxins on endocrine health:

Long-term effects: Investigating the long-term health effects of chronic, low-dose exposure to environmental toxins, considering cumulative effects and potential latency periods.

Synergistic effects: Studying the combined effects of multiple toxins, as individuals are often exposed to a mixture of chemicals in their environment.

Biomonitoring advances: Developing novel biomarkers and advanced analytical techniques, such as metabolomics and systems biology, to accurately assess human exposure levels and predict health outcomes.

Policy and regulatory strategies: Informing evidence-based policies and regulatory frameworks that prioritize human health protection and environmental sustainability.

Conclusion

In conclusion, environmental toxins pose significant challenges to human health through their disruptive effects on endocrine function. This discussion has underscored the importance of understanding the biochemical mechanisms underlying these disruptions, as well as their clinical implications and public health relevance. Addressing these challenges requires collaborative efforts across disciplines to advance research, implement effective policies, and safeguard human health in an increasingly complex environmental landscape.

References

1. Kampen KR (2012). Leuk Res 36: 6-13.

, , Crossref

2. Weir EG, Borowitz MJ (2001). Semin Hematol 38: 124-138.

, ,

3. Kruse A, Abdel-Azim N, Kim HN, Ruan Y, Phan V, et al. (2020). Int J Mol Sci 21: 1054.

, ,

4. Bianca B, Hergen S (2006). Annu Rev Immunol 24: 287-320.

, ,

5. Travlos GS (2006). Toxicol Pathol 34: 548-565.

, ,

6. Grewal A (2011). J Anaesthesiol Clin Pharmacol 27: 297-302.

, ,

7. Peng K, Liu HY, Wu SR, Cheng H, Ji FH, et al. (2015). Clin J Pain 31: 1097-1104.

, ,

8. Venn RM, Karol MD, Grounds RM (2002). Br J Anaesth 88: 669-675.

, ,

9. Ingrande J, Lemmens JM (2010). Br J Anaesth 105: i16-i23.

, ,

10. Kaur M, Singh PM (2011). Anesth Essays Res 5: 128-133.

, ,